James E Kirby
NIH Rank #19835
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1873165Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$493.9K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#19,835
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing James E Kirby as a PI. Multi-PI records show the full award amount for context.
- 1R21AI199146-01R21Development of next generation spectinomycin analogs that evade modifying enzyme-based resistance and show enhanced potency against multidrug-resistant pathogens.$493.9Kaward amount
Award organization
Organizations that administered FY2026 awards listing James E Kirby as a PI.
FY2026 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
- 2024$500K Cumulative Linked Award Amount
- 2025$1M Cumulative Linked Award Amount
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as James E Kirby.